Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Conditions: Nasopharyngeal Carcinoma; De-escalation Therapy Interventions: Drug: Cisplatin-based induction chemotherapy; Drug: Full course of PD-1/PD-L1 blockades; Radiation: Reduced-dose IMRT; Radiation: Standard-dose IMRT; Drug: Concurrent Chemotherapy Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital& Institute of Guangzhou Medical University; Guangdong Provincial People ' s Hospital; Second Affiliated Hospital, Sun Yat-Sen University; The fifth Affiliated Hospital of Guangzhou Medcial University; Zhongshan People ' s Hospital, Guangdong, China; Hunan Cancer Hospital; Tongji Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials